MediTrust Health, a financing service provider for the healthcare industry, has raised an undisclosed amount in its Series B round co-led by Ant Group, Sinovation Ventures, and Shanghai Biopharmaceutical Investment Fund, per an announcement.
China Renaissance’s new economy designated sub-fund Huaxing Growth Capital and Northern Light Venture Capital have also joined the round as new investors, while the company’ existing backers namely BioTrack Capital, Marathon Venture Partners, and SAIF Partners China have re-upped.
